Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;84(4):946-952.
doi: 10.1016/j.jaad.2020.12.046. Epub 2020 Dec 25.

Eruptions and related clinical course among 296 hospitalized adults with confirmed COVID-19

Affiliations

Eruptions and related clinical course among 296 hospitalized adults with confirmed COVID-19

Sergey Rekhtman et al. J Am Acad Dermatol. 2021 Apr.

Abstract

Background: Limited information exists on mucocutaneous disease and its relation to course of COVID-19.

Objective: To estimate prevalence of mucocutaneous findings, characterize morphologic patterns, and describe relationship to course in hospitalized adults with COVID-19.

Methods: Prospective cohort study at 2 tertiary hospitals (Northwell Health) between May 11, 2020 and June 15, 2020.

Results: Among 296 hospitalized adults with COVID-19, 35 (11.8%) had at least 1 disease-related eruption. Patterns included ulcer (13/35, 37.1%), purpura (9/35, 25.7%), necrosis (5/35, 14.3%), nonspecific erythema (4/35, 11.4%), morbilliform eruption (4/35, 11.4%), pernio-like lesions (4/35, 11.4%), and vesicles (1/35, 2.9%). Patterns also showed anatomic site specificity. A greater proportion of patients with mucocutaneous findings used mechanical ventilation (61% vs 30%), used vasopressors (77% vs 33%), initiated dialysis (31% vs 9%), had thrombosis (17% vs 11%), and had in-hospital mortality (34% vs 12%) compared with those without mucocutaneous findings. Patients with mucocutaneous disease were more likely to use mechanical ventilation (adjusted prevalence ratio, 1.98; 95% confidence interval, 1.37-2.86); P < .001). Differences for other outcomes were attenuated after covariate adjustment and did not reach statistical significance.

Limitations: Skin biopsies were not performed.

Conclusions: Distinct mucocutaneous patterns were identified in hospitalized adults with COVID-19. Mucocutaneous disease may be linked to more severe clinical course.

Keywords: COVID-19; Northwell; SarsCoV-2; adults; eruption; hospitalized; morbilliform; mucocutaneous; necrosis; purpura; rash; ulcer.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest Dr Garg has received honoraria from AbbVie, Amgen, Boehringer Ingelheim, Incyte, Janssen, Novartis, Pfizer, UCB, and Viela Bio. The rest of the authors have no conflicts to disclose.

Figures

Fig 1
Fig 1
Necrotic ulcer on the face at the placement of a medical device.
Fig 2
Fig 2
Purpura and necrosis involving the foot and toes.

References

    1. Shinkai K., Bruckner A.L. Dermatology and COVID-19. JAMA. 2020;324(12):1133–1134. - PubMed
    1. NYC Department of Health Coronavirus disease 2019 (COVID-19) https://www1.nyc.gov/site/doh/covid/covid-19-main.page Available at:
    1. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–c184. - PubMed
    1. Barros A.J., Hirakata V.N. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21. - PMC - PubMed
    1. Karagounis T.K., Shaw K.S., Caplan A., Lo Sicco K., Femia A.N. Acrofacial purpura and necrotic ulcerations in COVID-19: a case series from New York City. Int J Dermatol. 2020 doi: 10.1111/ijd.15181. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances